{
  "main_header": {
    "sid": 364572,
    "name": "Skybiotech Healt",
    "stock_name": "Skybiotech Healt",
    "full_name": "Skybiotech Healthcare Limited",
    "name_url": "stocks-analysis/skybiotech-healt",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "197.90",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "197.90",
    "mcapval": "38.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 512036,
    "symbol": "",
    "ind_name": "Garments & Apparels",
    "ind_code": 67,
    "indexname": "India SENSEX",
    "isin": "INE393H01016",
    "curr_date": "Jun 15",
    "curr_time": "",
    "bse_nse_vol": "21 ",
    "exc_status": "Active",
    "traded_date": "Jun 15, 2026",
    "traded_date_str": "2026 06 15",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/skybiotech-healt-364572-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Skybiotech Healthcare Limited is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/skybiotech-healthcare-limited-is-rated-strong-sell-3949143",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SkybiotechHealt_mojoScore_3949143.png",
        "date": "2026-04-16 10:10:16",
        "description": "Skybiotech Healthcare Limited is rated Strong Sell by MarketsMOJO. This rating was last updated on 16 Dec 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 16 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      }
    ],
    "total": 5,
    "sid": "364572",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/skybiotech-healthcare-limited-364572"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Submission Of Outcome Of Board Meeting And Submission Of Financial Results For The Quarter And Year Ended On 31St March 2026",
      "datetime": "30-May-2026",
      "details": "Submission of Outcome of board meeting and Financial Results for the quarter and year ended on 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Results Financials For The Year Ended On 31St March 2026",
      "datetime": "30-May-2026",
      "details": "Submission of Financial Results for the Quarter and Year ended on 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Approval Of Audited Results For The Quarter And Year Ended On March 31 2026",
      "datetime": "26-May-2026",
      "details": "Skybiotech Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Approval of Audited Results for the Quarter and Year ended on March 31 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Skybiotech Healthcare Limited is Rated Strong Sell

2026-04-16 10:10:16

Skybiotech Healthcare Limited is rated Strong Sell by MarketsMOJO. This rating was last updated on 16 Dec 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 16 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read More

View All News